
Urbopraz 40mg Tablet
Marketer
Octis Healthcare Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Urbopraz 40mg Tablet
Gastric acid production is diminished by the 40mg Urbopraz Tablet, a medication indicated for various gastrointestinal disorders. These include conditions like heartburn, acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptomatic relief and facilitating healing. Urbopraz 40mg also prevents stomach ulcers and hyperacidity often associated with prolonged nonsteroidal anti-inflammatory drug (NSAID) use. Classified as a proton pump inhibitor (PPI), it's best ingested an hour prior to meals, ideally in the morning. Dosage is individualized based on your condition and response, with continuous use advised even after symptom resolution. Dietary modifications such as smaller, more frequent meals, and avoidance of caffeine, spicy foods, and fatty items can enhance treatment efficacy. Common, usually mild, side effects encompass nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal discomfort. Persistent or bothersome side effects warrant medical consultation. Extended use, particularly exceeding one year, may heighten the risk of fractures, especially with higher dosages. Discuss bone loss prevention strategies, including calcium and vitamin D supplementation, with your physician. Prior to commencing treatment, inform your doctor about severe hepatic impairment, concomitant HIV medications, prior allergic reactions to similar drugs, or pre-existing osteoporosis. Pregnant or lactating individuals should seek medical guidance before use.
Uses of Urbopraz 40mg Tablet
Managing heartburn, gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Urbopraz 40mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Urbopraz 40mg tablets should be administered on an empty stomach.
Common Side effects of Urbopraz 40mg Tablet:
- Diarrhea
- Flatulence
- Headache
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Upper respiratory tract infection
How to use Urbopraz 40mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 40mg Urbopraz tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Urbopraz 40mg Tablet works:
Zegerid 40mg tablets belong to the proton pump inhibitor (PPI) class of drugs. Their mechanism involves decreasing gastric acid production, thereby alleviating heartburn and acid indigestion symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption with Urbopraz 40mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Urbopraz 40mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing. Consult your doctor for advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Urbopraz 40mg tablets appear compatible. Available human data indicate minimal infant risk associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by the side effects of Urbopraz 40mg Tablets.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Urbopraz 40mg Tablets are considered safe, and no dosage alteration is necessary.
LiverCAUTION
For individuals with severe hepatic impairment, the use of 40mg Urbopraz tablets requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Urbopraz 40mg Tablet :
Should you forget to take your Urbopraz 40mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Urbopraz 40mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Actions | Gastric acid suppressants |
